VTGN
Vistagen Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.25
+5.95%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.37
- Revenue estimate
- $500.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.30
- EPS estimate
- -$0.36
- Revenue actual
- $1.5M
- Revenue estimate
- $500.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +8.9%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.36 | -$0.30 | Beat 17.81% | $1.5M |
| Jun 16, 2026 | -$0.42 | -$0.37 | Beat 11.90% | $464.0K |
| Feb 12, 2026 | -$0.51 | -$0.45 | Beat 11.76% | $303.0K |
| Nov 13, 2025 | -$0.51 | -$0.54 | Miss -5.88% | $258.0K |
| Aug 7, 2025 | -$0.47 | -$0.47 | In line | $244.0K |
| Jun 17, 2025 | -$0.52 | -$0.43 | Beat 17.31% | -$15.0K |
| Feb 13, 2025 | -$0.48 | -$0.46 | Beat 4.17% | $234.0K |
| Nov 7, 2024 | -$0.40 | -$0.42 | Miss -5.00% | $183.0K |
| Jun 11, 2024 | -$0.34 | -$0.25 | Beat 26.47% | $197.3K |
| Feb 13, 2024 | -$0.31 | -$0.22 | Beat 29.03% | $411.4K |
| Nov 9, 2023 | -$0.68 | -$0.66 | Beat 2.94% | $278.0K |
| Aug 10, 2023 | -$0.86 | -$0.94 | Miss -9.30% | $177.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026